BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 36245043)

  • 1. HSF1 is a driver of leukemia stem cell self-renewal in acute myeloid leukemia.
    Dong Q; Xiu Y; Wang Y; Hodgson C; Borcherding N; Jordan C; Buchanan J; Taylor E; Wagner B; Leidinger M; Holman C; Thiele DJ; O'Brien S; Xue HH; Zhao J; Li Q; Meyerson H; Boyce BF; Zhao C
    Nat Commun; 2022 Oct; 13(1):6107. PubMed ID: 36245043
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Single-Cell Gene Expression Analyses Reveal Distinct Self-Renewing and Proliferating Subsets in the Leukemia Stem Cell Compartment in Acute Myeloid Leukemia.
    Sachs K; Sarver AL; Noble-Orcutt KE; LaRue RS; Antony ML; Chang D; Lee Y; Navis CM; Hillesheim AL; Nykaza IR; Ha NA; Hansen CJ; Karadag FK; Bergerson RJ; Verneris MR; Meredith MM; Schomaker ML; Linden MA; Myers CL; Largaespada DA; Sachs Z
    Cancer Res; 2020 Feb; 80(3):458-470. PubMed ID: 31784425
    [TBL] [Abstract][Full Text] [Related]  

  • 3. miR-34b Targets HSF1 to Suppress Cell Survival in Acute Myeloid Leukemia.
    Li G; Song Y; Zhang Y; Wang H; Xie J
    Oncol Res; 2016; 24(2):109-16. PubMed ID: 27296951
    [TBL] [Abstract][Full Text] [Related]  

  • 4. LncRNA MAGI2-AS3 inhibits the self-renewal of leukaemic stem cells by promoting TET2-dependent DNA demethylation of the LRIG1 promoter in acute myeloid leukaemia.
    Chen L; Fan X; Zhu J; Chen X; Liu Y; Zhou H
    RNA Biol; 2020 Jun; 17(6):784-793. PubMed ID: 32174258
    [TBL] [Abstract][Full Text] [Related]  

  • 5. IKZF2 Drives Leukemia Stem Cell Self-Renewal and Inhibits Myeloid Differentiation.
    Park SM; Cho H; Thornton AM; Barlowe TS; Chou T; Chhangawala S; Fairchild L; Taggart J; Chow A; Schurer A; Gruet A; Witkin MD; Kim JH; Shevach EM; Krivtsov A; Armstrong SA; Leslie C; Kharas MG
    Cell Stem Cell; 2019 Jan; 24(1):153-165.e7. PubMed ID: 30472158
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of altered growth factor receptor-mediated JAK2 signaling in growth and maintenance of human acute myeloid leukemia stem cells.
    Cook AM; Li L; Ho Y; Lin A; Li L; Stein A; Forman S; Perrotti D; Jove R; Bhatia R
    Blood; 2014 May; 123(18):2826-37. PubMed ID: 24668492
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PI3Kγ maintains the self-renewal of acute myeloid leukemia stem cells by regulating the pentose phosphate pathway.
    Gu H; Chen C; Hou ZS; He XD; Xie S; Ni J; Qian C; Cheng X; Jiang T; Yang C; Roberts TM; Zheng J; Varner JA; Armstrong SA; Zhao JJ
    Blood; 2024 May; 143(19):1965-1979. PubMed ID: 38271660
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Zeb1 modulates hematopoietic stem cell fates required for suppressing acute myeloid leukemia.
    Almotiri A; Alzahrani H; Menendez-Gonzalez JB; Abdelfattah A; Alotaibi B; Saleh L; Greene A; Georgiou M; Gibbs A; Alsayari A; Taha S; Thomas LA; Shah D; Edkins S; Giles P; Stemmler MP; Brabletz S; Brabletz T; Boyd AS; Siebzehnrubl FA; Rodrigues NP
    J Clin Invest; 2021 Jan; 131(1):. PubMed ID: 33108352
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [A TIM-3/galectin-9 autocrine stimulatory loop drives self-renewal of human myeloid leukemia stem cells and leukemia progression].
    Kikushige Y
    Rinsho Ketsueki; 2016 Apr; 57(4):412-6. PubMed ID: 27169443
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SYK inhibition targets acute myeloid leukemia stem cells by blocking their oxidative metabolism.
    Polak A; Bialopiotrowicz E; Krzymieniewska B; Wozniak J; Stojak M; Cybulska M; Kaniuga E; Mikula M; Jablonska E; Gorniak P; Noyszewska-Kania M; Szydlowski M; Piechna K; Piwocka K; Bugajski L; Lech-Maranda E; Barankiewicz J; Kolkowska-Lesniak A; Patkowska E; Glodkowska-Mrowka E; Baran N; Juszczynski P
    Cell Death Dis; 2020 Nov; 11(11):956. PubMed ID: 33159047
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression and functional relevance of long non-coding RNAs in acute myeloid leukemia stem cells.
    Bill M; Papaioannou D; Karunasiri M; Kohlschmidt J; Pepe F; Walker CJ; Walker AE; Brannan Z; Pathmanathan A; Zhang X; Mrózek K; LaRocco A; Volinia S; Bloomfield CD; Garzon R; Dorrance AM
    Leukemia; 2019 Sep; 33(9):2169-2182. PubMed ID: 30858548
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gata2 as a Crucial Regulator of Stem Cells in Adult Hematopoiesis and Acute Myeloid Leukemia.
    Menendez-Gonzalez JB; Vukovic M; Abdelfattah A; Saleh L; Almotiri A; Thomas LA; Agirre-Lizaso A; Azevedo A; Menezes AC; Tornillo G; Edkins S; Kong K; Giles P; Anjos-Afonso F; Tonks A; Boyd AS; Kranc KR; Rodrigues NP
    Stem Cell Reports; 2019 Aug; 13(2):291-306. PubMed ID: 31378673
    [TBL] [Abstract][Full Text] [Related]  

  • 13. NANOG Expression as a Responsive Biomarker during Treatment with Hedgehog Signal Inhibitor in Acute Myeloid Leukemia.
    Kakiuchi S; Minami Y; Miyata Y; Mizutani Y; Goto H; Kawamoto S; Yakushijin K; Kurata K; Matsuoka H; Minami H
    Int J Mol Sci; 2017 Feb; 18(3):. PubMed ID: 28245563
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Multi-kinase Inhibitor Debio 0617B Reduces Maintenance and Self-renewal of Primary Human AML CD34
    Murone M; Radpour R; Attinger A; Chessex AV; Huguenin AL; Schürch CM; Banz Y; Sengupta S; Aguet M; Rigotti S; Bachhav Y; Massière F; Ramachandra M; McAllister A; Riether C
    Mol Cancer Ther; 2017 Aug; 16(8):1497-1510. PubMed ID: 28468777
    [TBL] [Abstract][Full Text] [Related]  

  • 15. RNA Demethylase ALKBH5 Selectively Promotes Tumorigenesis and Cancer Stem Cell Self-Renewal in Acute Myeloid Leukemia.
    Shen C; Sheng Y; Zhu AC; Robinson S; Jiang X; Dong L; Chen H; Su R; Yin Z; Li W; Deng X; Chen Y; Hu YC; Weng H; Huang H; Prince E; Cogle CR; Sun M; Zhang B; Chen CW; Marcucci G; He C; Qian Z; Chen J
    Cell Stem Cell; 2020 Jul; 27(1):64-80.e9. PubMed ID: 32402250
    [TBL] [Abstract][Full Text] [Related]  

  • 16. WT1 facilitates the self-renewal of leukemia-initiating cells through the upregulation of BCL2L2: WT1-BCL2L2 axis as a new acute myeloid leukemia therapy target.
    Zhou B; Jin X; Jin W; Huang X; Wu Y; Li H; Zhu W; Qin X; Ye H; Gao S
    J Transl Med; 2020 Jun; 18(1):254. PubMed ID: 32580769
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CD93 Marks a Non-Quiescent Human Leukemia Stem Cell Population and Is Required for Development of MLL-Rearranged Acute Myeloid Leukemia.
    Iwasaki M; Liedtke M; Gentles AJ; Cleary ML
    Cell Stem Cell; 2015 Oct; 17(4):412-21. PubMed ID: 26387756
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of Slug effectively targets leukemia stem cells via the Slc13a3/ROS signaling pathway.
    Zhang Z; Li L; Wu C; Yin G; Zhu P; Zhou Y; Hong Y; Ni H; Qian Z; Wu WS
    Leukemia; 2020 Feb; 34(2):380-390. PubMed ID: 31492896
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HSP90 inhibitor 17-AAG selectively eradicates lymphoma stem cells.
    Newman B; Liu Y; Lee HF; Sun D; Wang Y
    Cancer Res; 2012 Sep; 72(17):4551-61. PubMed ID: 22751135
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diminished AHR Signaling Drives Human Acute Myeloid Leukemia Stem Cell Maintenance.
    Ly M; Rentas S; Vujovic A; Wong N; Moreira S; Xu J; Holzapfel N; Bhatia S; Tran D; Minden MD; Draper JS; Hope KJ
    Cancer Res; 2019 Nov; 79(22):5799-5811. PubMed ID: 31519687
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.